COVID-19

USF Health and Tampa General Hospital have been selected as a site for a clinical trial testing the Novavax NVX-CoV2373 vaccine for COVID-19.

A brief interruption in treatment for people who use immune-suppressing medicine can double the antibody response to COVID-19 booster vaccination.

Let’s say you have a runny nose, headache and cough. Are they signs of COVID-19 or just a run-of-the-mill common cold?

New research in Scotland has shed light on the challenging and difficult experiences of care home staff during the COVID-19 pandemic.

A new made-in-Alberta sanitization product aimed at stopping the spread of SARS-CoV-2 will soon be in use at the Edmonton International Airport and government offices in Calgary and Edmonton, thanks to a partnership with scientists at the University of Alberta’s Biosafety Level 3 Lab.

With the new academic year approaching, the University of Toronto is busy preparing for a limited and gradual return to campus in September.

Before COVID, university and vocational education students were at high risk of developing mental disorders, such as depression and anxiety. This is because they already experience much higher levels of psychological distress than the general population.

Professor Ananish Chaudhuri explores Covid-19 policy decisions, their implications, and cognitive biases in pandemic decision-making in his new book.

Support among Australians for the policy response to the coronavirus (COVID-19) pandemic and willingness to get vaccinated is high, according to new University of Melbourne research.

MIT spinout OPT Industries uses novel additive manufacturing systems to create intricately-designed products.